Gordon Ralph Corey, MD

Professor of Medicine
Gary Hock Professor in Global Health, in the School of Medicine
Vice-Chair for Education and Global Health in the Department of Medicine
Research Professor of Global Health
Professor of Pathology
Member in the Duke Clinical Research Institute
Campus mail 310 Trent Drive Room 235 Trent, Box 90519, Durham, NC 27708
Phone (919) 668-7174
Email address corey001@mc.duke.edu

My research is based at the Duke Clinical Research Institute, a large academic clinical research organization designed to conduct clinical trials from small local studies to worldwide trials. The focus of my research is bacterial infections: complicated skin and skin structure infections; postoperative wound infections; hospital-acquired and ventilator-associated pneumonia; bacteremia; and endocarditis. Many of these trials are conducted in concert with the pharmaceutical industry in order to register new antibiotics. In addition, as director of infectious diseases at the DCRI I oversee the work of the mycology group, and tuberculosis trials. This work also includes work supported by NIH grants including sepsis trials, the Staph Aureus and Staph Epi Bacteremia Groups, and the International Collaboration of Endocarditis. The team of investigators with whom I work is highly experienced, amazingly productive and wonderfully collegial.

As a result of my longstanding interest in tropical medicine and the generosity of my patients as well as the Hubert Family we have been able to establish the Hubert-Yeargan Center for Global Health. As a result we have developed a medical center-wide fellowship in Global Health. I am presently the Director of the Center and the Gary Hock Distinguished Professor of Global Health.

Education and Training

  • Fellowship, Infectious Diseases, Duke University School of Medicine, 1978 - 1980
  • Chief Resident, General Internal Medicine, Duke University School of Medicine, 1977 - 1978
  • Residency, General Internal Medicine, Duke University School of Medicine, 1975 - 1977
  • Internship, General Internal Medicine, Duke University School of Medicine, 1974 - 1975
  • M.D., Baylor University, 1973

Publications

Weems, J John, James P. Steinberg, Scott Filler, John W. Baddley, G Ralph Corey, Priya Sampathkumar, Lisa Winston, et al. “Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia..” Antimicrob Agents Chemother 50, no. 8 (August 2006): 2751–55. https://doi.org/10.1128/AAC.00096-06.

PMID
16870768
Full Text

Lalani, T., Z. A. Kanafani, V. H. Chu, L. Moore, G. R. Corey, P. Pappas, C. W. Woods, et al. “Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database..” Eur J Clin Microbiol Infect Dis 25, no. 6 (June 2006): 365–68. https://doi.org/10.1007/s10096-006-0141-z.

PMID
16767483
Full Text

Inrig, Jula K., Shelby D. Reed, Lynda A. Szczech, John J. Engemann, Joelle Y. Friedman, G Ralph Corey, Kevin A. Schulman, L Barth Reller, and Vance G. Fowler. “Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia..” Clin J Am Soc Nephrol 1, no. 3 (May 2006): 518–24. https://doi.org/10.2215/CJN.01301005.

PMID
17699254
Full Text

Stryjewski, Martin E., Vivian H. Chu, William D. O’Riordan, Brian L. Warren, Lala M. Dunbar, David M. Young, Marc Vallée, et al. “Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study..” Antimicrob Agents Chemother 50, no. 3 (March 2006): 862–67. https://doi.org/10.1128/AAC.50.3.862-867.2006.

PMID
16495243
Full Text

Kourany, Wissam M., Jose M. Miro, Asuncion Moreno, G Ralph Corey, Paul A. Pappas, Elias Abrutyn, Bruno Hoen, et al. “Influence of diabetes mellitus on the clinical manifestations and prognosis of infective endocarditis: a report from the International Collaboration on Endocarditis-Merged Database..” Scand J Infect Dis, 2006. https://doi.org/10.1080/00365540600617017.

PMID
16857604
Full Text

Chu, Vivian H., David R. Crosslin, Joelle Y. Friedman, Shelby D. Reed, Christopher H. Cabell, Robert I. Griffiths, Leah E. Masselink, et al. “Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes..” Am J Med 118, no. 12 (December 2005). https://doi.org/10.1016/j.amjmed.2005.06.011.

PMID
16378797
Full Text

Anderson, Deverick J., William Fangman, Vance G. Fowler, G Ralph Corey, and Daniel J. Sexton. “A returning traveler with fever and rash..” Clin Infect Dis 41, no. 10 (November 15, 2005): 1453–1530. https://doi.org/10.1086/497132.

PMID
16247837
Full Text

Cabell, Christopher H., Elias Abrutyn, Vance G. Fowler, Bruno Hoen, Jose M. Miro, G Ralph Corey, Lars Olaison, et al. “Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database..” Am Heart J 150, no. 5 (November 2005): 1092–98. https://doi.org/10.1016/j.ahj.2005.03.057.

PMID
16291004
Full Text

Wang, Andrew, Paul Pappas, Kevin J. Anstrom, Elias Abrutyn, Vance G. Fowler, Bruno Hoen, Jose M. Miro, et al. “The use and effect of surgical therapy for prosthetic valve infective endocarditis: a propensity analysis of a multicenter, international cohort..” Am Heart J 150, no. 5 (November 2005): 1086–91. https://doi.org/10.1016/j.ahj.2005.01.023.

PMID
16291003
Full Text

Pages